Bloodwork question about tirzepatide. Baseline, five years in, and the numbers moved in a direction I did not expect.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took five years to be sure.
If you need three other compounds to notice the first one, you have not tested the first one.
Muscle loss is the thing to watch, which means protein and resistance training rather than appetite alone.
What is the strongest human evidence anyone here has actually read, not skimmed?
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Same here.
Same here.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation. Five years in on tirzepatide and it lines up.
Most of what is called evidence here is one person, one vial, one month.
What is the first thing you would read if you were starting from zero? Currently on tirzepatide myself.
Cold storage, light protection, date on the vial. Boring, removes half the variables. Currently on tirzepatide myself.
Where does the human data stop and the extrapolation begin? That is the whole thread. Currently on tirzepatide myself.
Stupid question: how do you know whether what is in the vial matches the label at all? Same for me with tirzepatide, unfortunately.
Read methods.